In hepatic toxicity induced in rats by two injections of thioacetamide (TAA, 350 mg/kg with an interval of 8 hr), the action of quercetin was investigated. After 96 hr, TAA administration resulted in hepatic necrosis, significant increases in serum transaminase activity, and increases in hepatic lipoperoxidation. Thioacetamide-induced hepatotoxicity also showed changes in antioxidant enzymes in the liver of rats, with alterations in p-ERK 1/2 (phosphorylated extracellular-signal related kinase 1/2) as well as an imbalance between proapototic protein Bax and anti-apoptotic protein Bcl-2 expression. With administration of the flavonoid quercetin (50 mg/Kg i.p.) for four consecutive days following TAA, serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activity were close to normal values in rats. Histological findings suggested that quercetin had a preventive effect on TAA-induced hepatic necrosis. Quercetin treatment caused significant decreases in lipid peroxide levels in the TAA-treated rats, with some changes in antioxidant enzymes superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). Quercetin also inhibited the change of the p-ERK1/2 by TAA and significantly prevented the increase in Bax/Bcl-2 ratio, thus preventing apoptosis. Findings indicate that quercetin may have a preventive effect on TAA-induced hepatotoxicity by modulating the oxidative stress parameters and apoptosis pathway.
INTRODUCTION
Appropriate animal models have contributed to our understanding of the mechanisms responsible for hepatotoxic injury. The pathological lesions caused by hepatotoxins may be similar to many forms of liver disease, contributing to the evaluation of novel potential hepatoprotectants (Abul et al. 2002; Bruck, Aeed, Avni, et al. 2004) .
Hepatotoxins initially damage the centrilobular regions of liver where there are high levels of cytochrome P450 oxidases that mediate their conversion to toxic intermediates, followed by reactive oxygen species (ROS) production, lipid peroxidation, and release of pro-inflammatory cytokines (Luster et al. 2000) . Thus, thioacetamide (TAA) is a hepatotoxin causing centrilobular necrosis (Zimmerman 1978; Diez-Fernandez et al. 1993; Diez-Fernandez, Sanz, and Cascales 1996; Mangipudy et al. 1998; Chu et al. 2000) , which has been shown to also induce apoptosis and periportal inflammatory cell infiltration in rat liver (Ledda-Columbano et al. 1991) . Thioacetamide causes an elevation of oxidative stress, enhancing free radicalmediated damage to proteins, lipids and deoxyribonucleic acid (DNA) (Lu et al. 1999; Bruck, Aeed, Shirin, et al. 2004; Tunez et al. 2005; Uskokovic-Markovic et al. 2007 ). Thioacetamide induces hepatotoxicity via its S-oxide metabolite (thioacetamide-S-dioxide), an unstable, reactive metabolite, that initiates necrosis and the generation of reactive oxygen species (ROS) by binding covalently to liver macromolecules (Porter and Neal 1978) . Several studies have demonstrated the beneficial effect of antioxidants in protecting the liver against TAA-induced injury (Balkan et al. 2001; Uskokovic-Markovic et al. 2007; Baskaran, Periyasam, and Venkatraman 2010) . TAA induces hepatocyte damage following its metabolism to thioacetamide sulphene and sulphone, via a critical pathway that involves CYP4502E1-mediated biotransformation (T. Wang et al. 2000; Ramaiah, Apte, and Mehendale 2001) .
Flavonoids are a large group of natural polyphenolic substances widely distributed in the plant kingdom that can act as antioxidants in biological systems. Quercetin (3, 3', 4', 5, 7pentahydroxyflavone) , one of the most abundant flavonoids, is present in large amounts in vegetables, fruits, tea, and olive oil. It contains a number of phenolic hydroxyl groups and is a potent oxygen free radical scavenger and a metal chelator (Middleton 1998) . It has been demonstrated that quercetin exhibits its therapeutic potential against many diseases, including ischemic heart diseases, atherosclerosis, liver fibrosis, renal injury, and chronic biliary obstruction (Peres et al. 2000; Singh, Chander, and Chopra 2004; Tieppo et al. 2007) . In this context, the present study was designed to highlight the mechanisms involved in an experimental model of TAA-induced hepatotoxicity and to determine if the treatment with quercetin exerts a beneficial effect.
MATERIALS AND METHODS

Animals:
All procedures related to the rats were carried out according to the guidelines of the Ethical Research Commission in Health of the Research and Graduate Group of the Hospital de Clínicas of Porto Alegre (HCPA) (Goldin and Raymundo 1997) . Two-month-old male Wistar rats with a mean weight of 250 g were used. The animals were obtained from the State Foundation in Health Production and Research, Porto Alegre. They were kept in the Animal Experimentation Unit at the Research Center of the HCPA in plastic cages measuring 47 Â 34 Â 18 cm lined with wood chips, under a 12 hr light/ dark cycle and temperature between 20-25 C. They received water and food ad libitum.
Experimental Procedure: Twenty-eight male Wistar rats were randomized in four groups: CO ¼ Control Group (n ¼ 7), Q ¼ Control Group undergoing treatment with quercetin (n ¼ 7), TAA ¼ Thioacetamide Group undergoing treatment with thioacetamide (n ¼ 7), and TAA þ Q ¼ Thioacetamide Group undergoing treatment with quercetin (n ¼ 7). The TAA groups were injected with two doses of TAA (350 mg/kg i.p.) with an interval of 8 hr. Treatment with quercetin (50 mg/kg) was initiated 2 hr after the second dose of TAA, and the animals received four doses of quercetin (Sigma Chemical, St. Louis, MO, USA) i.p., at intervals of 24 hr. At day 5, rats were anesthetized using ketamine (100 mg/ kg) and xylazine (10 mg/kg) and killed by exsanguination. Tissues were collected and stored at -80 C.
Blood Analysis: Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were determined by commercial kits (Boehringer Mannheim, Mannheim, Germany).
Histological Analysis: Thin slices of the left lobes of the livers from each group were collected and kept for 48 hr in a 10% formaldehyde solution. After paraffin embedding, tissues were sectioned and stained with hematoxylin and eosin (H&E) for histological studies.
Oxidative Stress and Antioxidant Assay:
Frozen tissue from each rat was homogenized in ice-cold phosphate buffer (140 mM KCl, 20 mM phosphate, pH 7.4) and centrifuged at 1,500 g for 10 minutes. Oxidative stress was determined by measuring the concentration of aldehydic products by thiobarbituric acid reactive substances (TBARS) (Buege and Aust 1978) . Spectrophotometric absorbance of the supernatant at 535 nm was determined. Cytosolic superoxide dismutase (SOD) (EC 1.5.1.1) was assayed at 30 C according to Misra and Fridovich (Misra and Fridovich 1972) . The autoxidation rate of epinephrine, which is progressively inhibited by increasing amounts of SOD in the homogenate, was monitored spectrophotometrically at 560 nm. The amount of enzyme that inhibited 50% of epinephrine autoxidation was defined as 1 U of SOD activity. Catalase (CAT) activity was determined by measuring the decrease in absorption at 240 nm in a reaction medium containing 50 mM phosphate buffer (pH 7.2) and 0.3 M hydrogen peroxide (Boveris and Chance 1973) . The enzyme activity was assayed spectrophotometrically at 240 nm. The glutathione peroxidase (GPx) activity was determined by the oxidation rate of nicotinamide adenine dinucleotide phosphate (NADPH) in the presence of reduced glutathione and glutathione reductase (Flohe and Gunzler 1984) .
Nitric Oxide Metabolites: Nitric oxide production in liver tissue was measured indirectly using a quantitative colorimetric assay based on the Griess reaction as previously described by Granger et al. (1999) . It measures one of the stable end products of nitric oxide, that is, nitrite. Aliquots of 50 mL were incubated with enzyme cofactors and nitrate reductase for 30 minutes at room temperature for the conversion of nitrate to nitrite. The nitrite formed was then analysed by reaction with the Griess reagent, forming a coloured compound that was measured by spectrophotometer at a wavelength of 540 nm (Granger et al. 1999) .
Western Blot Analysis: For protein isolation, liver tissues in different treatment groups were prepared in the presence of proteases and phosphatase inhibitors. Lysate proteins were fractionated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and Western blotting was performed using the corresponding primary antibodies. Bound antibody was detected by enhanced chemiluminescence. Membrane rehybridization with b-actin antibody was performed for loading accuracy (Tunon et al. 2003) . Antibodies anti-p-ERK1/ 2, anti-Bcl-2, and anti-Bax were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Polyclonal anti-b-actin Statistical Analysis: The results were expressed as mean + SD. The data were compared by analysis of variance (ANOVA); when the analysis indicated the presence of a significant difference, the means were compared with the Duncan test. Significance was accepted at p .05. All calculations were performed using the SPSS 14.0 statistical software.
RESULTS
Blood Analysis:
TAA administration resulted in a marked increase in the levels of serum aminotransferase, compared with untreated rats (Table 1) . This increase was significantly decreased in rats that received quercetin for four days (p .05).
Histopathology:
Examination was performed on liver specimens obtained four days after TAA injection to confirm the biochemical findings. The histological analysis of liver tissue from animals in the control group (Figure 1a ) or from the rats receiving quercetin alone ( Figure 1b ) exhibited normal hepatocytes with well-preserved cytoplasm and nucleus. The livers of rats treated with TAA alone exhibited residual perivenular necrosis with infiltration of lymphocytes and macrophages ( Figure 1c ). The changes were minimal in rats treated with quercetin after TAA-induced hepatic injury. This group exhibited less inflammatory cell infiltration (Figure 1d ).
Oxidative Stress and Antioxidant:
The TBARS levels were significantly increased in rats that received TAA alone, compared with control rats (Figure 2 ). Quercetin treatment FIGURE 1.-Micrographs of hepatic tissue (original magnification: 200x). Livers of control rats (a); control treated with quercetin rats (b); tioacetamide-injected rats (c); tioacetamide-injected rats treated with quercetin (d). Tissue samples were stained with hematoxylin-eosin (HE). CV, centrilobular vein. Control liver shows normal structures (a, b), whereas residual necrosis and infiltration of lymphocytes and macrophages were seen in perivenular area of TAA-injected rats (c). Quercetin treatment shows reduced amount of periportal cell infiltration (d). Vol. 39, No. 6, 2011 HEPATOPROTECTIVE QUERCETIN significantly reduced hepatic TBARS levels when compared with TAA alone, but did not restore the TBARS to control levels (p .05; Figure 2 ). Our results showed that the hepatic SOD activity increased significantly in the group that received TAA alone (p .05; Table 2 ). However, in the group that received TAA and quercetin, the hepatic SOD activity was significantly decreased in comparison with the TAA group, returning to levels near to controls. In contrast, the hepatic CAT activity was significantly decreased in the TAA group (p .05; Table 2 ), while treatment with quercetin after TAA significantly increased the CAT activity compared to the control group. A significant increase in GPx activity from the liver homogenates was observed in rats treated with TAA (p .05; Table 2 ). However, in the group treated with quercetin after TAA administration, GPx activity was significantly decreased in comparison to the TAA group (p .05), but higher than in the control group.
Nitric Oxide Metabolite: Figure 3 shows that nitrite/ nitrate levels in liver homogenates were significantly elevated in the TAA group (p .05). The treatment with quercetin showed markedly decreased nitrite/nitrate levels compared to the TAA-induced group (p .05), returning to the levels similar to the control.
Western Blot:
Phosphorylated ERK1/2 was significantly decreased in rats treated with TAA compared with the control group. There were no changes observed in ERK1/2 phosphorylation by quercetin treatment (Figure  4 ). Figure 5 demonstrates representative Western blots of Bcl-2 and Bax expression in animals without and with quercetin treatment. Densitometric analysis revealed that Bax expression was significantly increased and Bcl-2 expression significantly reduced in TAA group. Treatment with quercetin significantly prevented these changes, resulting in a significantly lower Bax/Bcl-2 ratio when compared to TAA rats ( Figure 5 ).
DISCUSSION
The present study evaluated the effects of quercetin treatment on liver injury resulting from TAA administration. TAA treatment caused a significant increase in the activity levels of serum ALT and AST, and quercetin reduced those levels. Histopathological data also point toward a protective effect of quercetin against TAA-induced liver injury. Histopathological analysis showed that lesions of periportal hepatic cells with periportal necrosis and macrophage infiltration in the TAA group were ameliorated in rats receiving quercetin following the induction of liver damage. Nitric oxide (NO) is a potent biological mediator produced by hepatocytes after exposure to cytokines (Geller et al. 1994; Kang, Berthiaume, and Yarmush 2002 ) that influences physiological processes in every organ and tissue (X. Yao, Chen, and Li 2009) . It is rapidly oxidized in blood and tissues to form nitrate and nitrite (Shaker et al. 2010) . Production of NO can be determined by measuring liver nitrite and nitrate levels (X. Yao, Chen, and Li 2009), and its activity is regulated at the transcriptional level by cytokines and the exposure of cells to other inflammatory stimuli such as (Manjeet and Ghosh 1999) . The indiscriminate destruction of cells and tissues by NO and its reactive nitrogen intermediates may be involved in the pathology of many inflammatory disorders, such as sepsis and severe gastroenteritis, where the levels of nitrate and nitrite are greatly increased (Moncada and Higgs 1993; Herulf et al. 1999; Crawford et al. 2004 ). Quercetin and its glycoside quercitrin have been found previously to have anti-inflammatory effects both in in vitro and in experimental models of inflammatory diseases (Camuesco et al. 2004; Comalada et al. 2006 ). Quercetin is a strong oxygen radical scavenger and also a good metal chelator (Jovanovic et al. 1998) . In vitro studies have suggested that quercetin has a potent inhibitory activity against the production of NO and tumor necrosis factor in lipopolysaccharide-stimulated Kupffer cells (Kawada et al. 1998) . Quercetin was also shown to reduce the serum levels of NO in streptozotocin-treated rats (Coskun et al. 2005 ) and to scavenge superoxide in ischemia-reperfusion injury (Huk et al. 1998 ). Thus, the elevated liver nitrite and nitrate levels observed in our study are in agreement with previous data in different animal models of liver injury (Isobe et al. 2000; Shaker et al. 2010) . This indicates that the hepatic injury produced by TAA treatment could be a consequence of oxidative stress. This oxidative stress results from the increased generation of ROS, which have been reported to attack various biological molecules and causing lipid peroxidation.
In the current study, the increased activity of SOD reflects an activation of the compensatory mechanism through the effects of TAA on progenitor cells, and its extent depends on the magnitude of the oxidative stress and, hence, on the dose of the stressors (Prakasam, Sethupathy, and Lalitha 2001) . Increased activity of GPx could be due to the significant production of H 2 O 2 in TAA-induced toxicity (Chen, Hsu, and Weng 2006) .
Quercetin maintained the activities of SOD and GPx similar to control levels. However, TAA reduced the levels of CAT activity, which may cause the accumulation of O 2 -, H 2 O 2 , or their products of decomposition. Loss of CAT activity results in oxygen intolerance and triggers a number of deleterious reactions such as protein and DNA oxidation and cell death (Bruck et al. 1999 ). Treatment with quercetin may have prevented large increases in activity of antioxidant enzymes SOD and GPx, as observed for TAA group. Animals treated with the antioxidant quercetin also showed an increased catalase activity. Flavonoids, and quercetin in particular, are potent antioxidants and are known to modulate the activities of different enzymes due to their interactions with various biomolecules. The cytoprotective effect of quercetin may also be due to its ability to interact with and penetrate the lipid bilayer (Behling et al. 2006 ).
There are two overlapping signaling pathways leading to apoptosis, termed intrinsic and extrinsic pathways. The Bcl-2 protein family plays a role in the regulation of the intrinsic pathway. Two key representative members of this family are the anti-apoptotic Bcl-2 and the pro-apoptotic Bax (Narita et al. 1998 ). The two apoptotic pathways are not mutually exclusive in hepatocytes but are closely interrelated, as the mitochondrial pathway is often required to amplify the relatively weak death receptor-induced apoptotic signal (Ghavami et al. 2005) . The Bcl-2 functions to prevent cell death, whereas Bax, which forms hetero-dimers with Bcl-2, appears to accelerate the cell death signal (Oltvai, Milliman, and Korsmeyer 1993) . Increases in ROS production and mitogen-activated protein kinase (MAPK) activation result in an imbalance between anti-and pro-apoptotic Bcl-2 family proteins, membrane permeability transition, release of cytochrome c, and further production of ROS, which contributes to the susceptibility of a given cell to apoptosis (Oltvai, Milliman, and Korsmeyer 1993) . In a nonalcoholic steatohepatitis model, it was observed that significant increases of Bax protein concentration in the livers of rats fed the high-fat diet occurred. This increase of Bax pro-apoptotic protein without changes of Bcl-2/Bcl-xl anti-apoptotic proteins, associated with oxidative stress, may lead to an imbalance within the Bcl-2 family, which then mediates mitochondrial dysfunction and cell apoptosis (Y. Wang et al. 2008) . Overexpression of Bcl-2 and Bcl-xl, reducing the Bax/Bcl-2 and Bax/Bcl-xl ratio, have recently been reported to inhibit ROS production, cytosolic cytochrome c release and poly (ADP-ribose) polymerase (PARP) degradation-mediated apoptosis and mediated autophagy in a renal ischemia/ reperfusion study (Wu et al. 2009 ). Cytosolic protein content for both molecules was studied by Western blot. Our results confirm that Bax expression was significantly increased and Bcl-2 expression significantly reduced at four days after TAA-induced liver toxicity in rats. Treatment with quercetin significantly prevented those changes, resulting in a significantly lower Bax/Bcl-2 ratio when compared with untreated rats. These results are in agreement with findings in a study of apoptosis mediated by H 2 O 2 . Quercetin markedly inhibited the apoptotic characteristics via reduction of intracellular reactive oxygen species generation. Also, it prevented the H 2 O 2 -mediated mitochondrial dysfunction, including disruption of mitochondria membrane permeability transition as well as an increase in expression of apoptogenic Bcl-2 proteins, Bcl-2 and Bcl-xl (Park et al. 2003) .
MAPKs are proposed to play a key role in intracellular signaling cascades in normal and pathogenic conditions (Raman, Chen, and Cobb 2007; Y. Wang 2007) . The activation of MAPK is linked with cell death in the rat liver via oxidative stress (Iida et al. 2009 ). Extracellular-signal related kinase (ERK) functions cytoprotectively against apoptosis that is triggered by oxidative stress (Czaja, Liu, and Wang 2003; Y. Wang et al. 2004; Tommasini et al. 2005) , tumor necrosis factor-alpha (TNF-a) (Xia et al. 1995; Gardner and Johnson 1996) , NO (Bhat et al. 1998; Mi Jeong, Davaatseren and Kim 2009) , and proapoptotic drugs (Stadheim and Kucera 1998) . Phosphorylated ERK1/2 significantly increased soon after liver injuries (Kishioka et al. 2007; Garcia-Lastra et al. 2010; Kitamura et al. 2010) . In a rat model of liver ischemia for 45 min and reperfusion, phosphorylated ERK2 increased 
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DE DAVID ET AL. TOXICOLOGIC PATHOLOGY significantly 1.5 hr after reperfusion in both the ischemic and non-ischemic regions (Kitamura et al. 2010) . A model of rabbit hemorrhagic disease showed that expression of phosphorylated p-ERK1/2 was significantly elevated at 12 hr pi, and at 48 hr pi there was no p-ERK1/2 expression (Garcia-Lastra et al. 2010 ).
In the present study, p-ERK1/2 was decreased in TAA-induced rats four days after liver toxicity. These findings imply that the activation of p-ERK1/2 could take place earlier and that the strong apoptotic and necrotic signals induced by a high dose of TAA could block cell responses to growth and survival factors acting through the ERK pathway. Currently, the most effective therapy for acute or chronic hepatic failure is orthotopic transplantation (Ahmed and Keeffe 2007) . A number of beneficial effects of quercetin on human health have been shown (P. Yao et al. 2007; Boots, Haenen, and Bast 2008) , and some studies have indicated an important role for quercetin in protecting against the deleterious effects of reactive oxygen species and in the inhibition of redox-sensitive signaling pathways in several diseases (Moreira et al. 2004; Dias et al. 2005; Amic et al. 2007; Tieppo et al. 2009 ).
In summary, we confirmed literature findings that hepatocyte apoptosis was significantly increased in liver injury induced by TAA. Our findings indicate that the increased oxidative stress and its associated pERK1/2 activation as well as an imbalance of pro-and anti-apoptotic proteins in the Bcl-2 family all contributed to high hepatocyte apoptosis that may play a significant role in the pathogenesis of TAA-induced liver injury. Quercetin, inhibiting the oxidative stress and/or directly intervening in apoptotic pathways, as demonstrated in our study, could represent a potential valid therapeutic drug for liver toxicity.
